Definitive Healthcare Corp. Stock Price, News & Analysis

Definitive Healthcare (Nasdaq: DH) announced it will release its fourth quarter and full year financial results on February 23, 2023, after market close. The company will hold a conference call at 5:00 PM ET to discuss the results. Investors can listen to the event via a live audio webcast on the Definitive Healthcare Investor Relations website. The replay of the call will be available until March 9, 2023, for those who cannot attend the live session.

Definitive Healthcare specializes in healthcare commercial intelligence, aiding clients in identifying market opportunities.

Definitive Healthcare (Nasdaq: DH) announced the launch of its Atlas Dataset, a comprehensive resource for healthcare commercial intelligence. This dataset integrates information on over 15 million healthcare professionals and 300,000 organizations, positioning it as a leading tool for clients to make informed decisions. An independent survey indicated the dataset's top ranking for reference and affiliation data. It includes key components such as Atlas Reference & Affiliation, All-Payor Claims, and Prescription Claims, enhancing visibility into healthcare operations and contributing to improved market understanding.

Definitive Healthcare (Nasdaq: DH) reported a 60% increase in its Atlas Prescription Claims and significant growth in Atlas All-Payor Claims. This expansion enhances data for healthcare providers to improve patient outcomes, particularly in areas like rare diseases and oncology, with nearly 20% increases in these sectors. CEO Robert Musslewhite emphasized the value of the expanded dataset for driving commercial success, refining methodologies, and increasing patient cohort accuracy. The updated Atlas Dataset equips clients with comprehensive insights into patient care, provider behavior, and market trends.

Definitive Healthcare Corp. (Nasdaq: DH) announced its participation in the 25th Annual Needham Growth Conference. CEO Robert Musslewhite and CFO Rick Booth will present on January 11, 2023, at 11:00 a.m. ET. Interested parties can access the live webcast via the Definitive Healthcare investor relations website.

The company is recognized for its healthcare commercial intelligence, using data and analytics to assist clients in navigating market opportunities effectively.

Definitive Healthcare (Nasdaq: DH) has been recognized as one of the Top Places to Work in Massachusetts for the sixth consecutive year by The Boston Globe. The award is based on surveys of employee satisfaction, assessing factors like leadership and workplace culture. CEO Robert Musslewhite highlighted the company’s commitment to an inclusive culture and employee development. Additionally, Definitive Healthcare was named a Top Workplace in the United States by Energage. The company actively promotes diversity and engages in community support through its DefinitiveCares initiative.

Definitive Healthcare Corp. (Nasdaq: DH) has appointed Jon Maack as President effective November 3, 2022. Maack, who brings extensive experience in healthcare SaaS, will oversee product management, engineering, corporate strategy, and M&A, reporting to CEO Robert Musslewhite. Maack previously served as Chief Strategy Officer at athenahealth and held senior roles at Optum and Bain & Company. He expressed excitement about joining Definitive Healthcare, emphasizing the untapped potential in the healthcare commercial intelligence market as they aim to enhance tools for their customer base of over 3,000.

Definitive Healthcare Corp. (Nasdaq: DH) reported a 33% year-over-year revenue growth to $57.4 million for Q3 2022. The net loss narrowed to ($6.4) million from ($21.0) million in Q3 2021, representing 11% of revenue. Adjusted net income rose to $8.9 million with adjusted EBITDA at $16.4 million, or 29% of revenue. The company continues to gain traction with new customers and product launches, including Passport Express. For Q4 2022, it expects revenue between $58-59 million, a 26% increase year-over-year.

Definitive Healthcare Corp. (Nasdaq: DH) will release its third-quarter financial results for the period ending September 30, 2022, on November 3, 2022, after market close. A conference call and webcast to discuss these results will take place at 5:00 PM ET. Investors can access a live audio webcast on the company’s Investor Relations website. A replay will be available until November 17, 2022. Definitive Healthcare specializes in healthcare commercial intelligence, helping clients navigate market opportunities through its SaaS platform.

Definitive Healthcare (Nasdaq: DH) announced its commitment to the UN Global Compact, the largest corporate sustainability initiative globally, aimed at aligning operations with ten principles covering human rights, labor, environment, and anti-corruption.

CEO Robert Musslewhite emphasized the company's dedication to community betterment and transparency in sustainability efforts. The company also focuses on diversity, equity, and inclusion, enhancing hiring processes and engaging employees in community service through its DefinitiveCares program, while minimizing its environmental impact.